Lundergan, C.F.

patient diabetes infarction mortality nondiabetic patients artery nondiabetic angiographic ejection fraction survival variable function hospital 30- day mortality study grade therapy timi flow grade thrombolytic therapy 30 days thrombolysi group analysis ejection fraction thrombolytic trial hazard difference infarct-related patency ratio reperfusion angioplasty 30- hazard ratio angiographic variables swets subs service tissue plasminogen activator effect infarct-related artery patency heart number angiography artery disease streptokinase follow-up hazard ratios center diabetes mellitus survival curves outcome determinant death investigator randomized curve angiographic findings 90 min 90- rescue angioplasty gusto-i adjustment 0.0001 disease activator table plasminogen 2- year mortality benefit result treatment 2 years heart failure infarct-related artery chord hopital diabetic multivariable university